SEC Filings TLDR

This Amendment No. 3 to Schedule 13D, filed by Samsara BioCapital, L.P., Samsara BioCapital GP, LLC, Samsara Opportunity Fund, L.P., Samsara Opportunity Fund GP, LLC, and Dr. Srinivas Akkaraju, updates the ownership details of common stock in Scholar Rock Holding Corp. The amendment includes transactions where Samsara ...

Yunqi Capital Limited and other Reporting Persons have filed an amendment to their Schedule 13D regarding their investment in STAAR Surgical Co. The amendment details their opposition to the proposed merger with Alcon, citing concerns over the valuation of the company and the process leading to the merger agreement. Th...

This Amendment No. 5 to Schedule 13D, filed by Pogo Royalty, LLC, CIC Pogo LP, CIC IV GP LLC, CIC Partners Firm LP, and CIC Partners Firm GP LLC, updates the ownership details of Class A Common Stock of EON Resources Inc. The amendment reflects that the Reporting Persons now own less than 5% of the Class A Common Stock...

This Amendment No. 4 to Schedule 13D is filed by AI ETI LLC, Access Industries Holdings LLC, Access Industries Management, LLC, and Len Blavatnik (collectively, the "Reporting Persons") regarding their holdings in Climb Bio, Inc. (formerly known as Eliem Therapeutics, Inc.). The amendment reflects material changes sinc...

This Amendment No. 4 to Schedule 13D, filed by Chintu Patel, updates the ownership and transaction details related to Class A Common Stock of Amneal Pharmaceuticals, Inc. The amendment reports that on October 3, 2025, a trust controlled by Patel contributed 13,257,287 shares of Class A Common Stock to Shivkan Holdings ...

This filing is an amendment to Schedule 13D for Alzamend Neuro, Inc., submitted by various reporting persons including Milton C. Ault, III, William B. Horne, Henry C.W. Nisser, Kenneth S. Cragun, and David J. Katzoff. The amendment updates the ownership details and transactions involving the company's common stock and ...

BML Investment Partners, L.P. and Braden M. Leonard have sold all their shares in Astrotech Corporation, as reported in an amendment to their Schedule 13D filing. On October 3, 2025, BML Investment Partners sold 220,410 shares at a weighted average price of $7.1305, while Braden M. Leonard sold 9,166 shares at $5.83. T...

Howard W. Lutnick has completed his divestiture from XBP Global Holdings, Inc., as announced in connection with his appointment as the U.S. Secretary of Commerce. The sale of his interests in Cantor and CFGM was finalized on October 6, 2025, resulting in Mr. Lutnick no longer holding any voting or dispositive power ove...

This Amendment No. 4A to Schedule 13D, filed by CFAC Holdings VIII, LLC, Cantor Fitzgerald, L.P., CF Group Management, Inc., and Brandon G. Lutnick, updates the beneficial ownership of common stock in XBP Global Holdings, Inc. The amendment reflects the completion of Howard W. Lutnick's divestiture of his holdings in C...

This Amendment No. 4 to Schedule 13D, filed by Reprogrammed Interchange LLC and Reid Hoffman, updates the previously filed Schedule 13D. The amendment reports significant sales of Vor Biopharma Inc. Common Stock by Reprogrammed Interchange LLC from September 12, 2025, to October 3, 2025. The sales resulted in a decreas...

This Amendment No. 9 to Schedule 13D, jointly filed by Mat Ishbia and SFS Holding Corp., pertains to the Class A Common Stock of UWM Holdings Corporation. The amendment reflects sales of securities that have occurred pursuant to a 10b5-1 trading arrangement previously disclosed in Amendment No. 8. As of the date of thi...

Deutsche Telekom AG and its subsidiaries filed Amendment No. 34 to Schedule 13D for T-Mobile US, Inc. The amendment discloses that the reporting persons beneficially own 628,168,603 shares of T-Mobile's common stock, representing 55.8% of the outstanding shares. The amendment also includes details of a call option agre...

This Amendment No. 4B to the Schedule 13D filed by Howard W. Lutnick indicates that he no longer has any voting or dispositive power over the securities of Satellogic Inc. and therefore ceases to be a Reporting Person. The amendment reflects the completion of Mr. Lutnick's divestiture of his holdings in Cantor and CFGM...

This Amendment No. 4A to Schedule 13D, filed by Cantor Fitzgerald, L.P., CF Group Management, Inc., CFAC Holdings V, LLC, Cantor Fitzgerald & Co., Cantor Fitzgerald Securities, and Brandon G. Lutnick, updates their beneficial ownership of Class A Common Stock of Satellogic Inc. The amendment reflects the completion of ...

StepStone Group LP has filed an amendment to its Schedule 13D for NeueHealth, Inc., indicating that all shares of Common Stock held by the Reporting Persons were canceled and extinguished on October 2, 2025, in connection with the issuer's previously announced business combination. As a result, each of the Reporting Pe...

This Amendment No. 9 to Schedule 13D, filed on October 6, 2025, pertains to the common stock of NeueHealth, Inc. The filing is made by New Enterprise Associates (NEA) and its affiliated entities, including NEA 15, NEA 16, NEA 17, and NEA 18 Venture Growth Equity, among others. The amendment provides updates on the owne...

Howard W. Lutnick, former Executive Chairman of Newmark Group, Inc., has completed the divestiture of his holdings in the company. This action follows his appointment as the U.S. Secretary of Commerce. The divestiture, which was finalized on October 6, 2025, results in Mr. Lutnick no longer holding any voting or dispos...

Amendment No. 5A to Schedule 13D for Newmark Group, Inc. discloses the completion of Howard W. Lutnick's divestiture of his holdings in the company following his appointment as U.S. Secretary of Commerce. The amendment details the transfer of voting shares of CF Group Management, Inc. (CFGM) and interests in Tangible B...

This Amendment No. 1 to the Schedule 13D filed by Robert E. Dixon provides updated information regarding his beneficial ownership of shares in MacKenzie Realty Capital, Inc. As of October 3, 2025, Dixon beneficially owns 124,719 shares, representing approximately 7.1% of the outstanding common stock. The amendment deta...

Franklin Resources, Inc. (FRI), along with Charles B. Johnson, Rupert H. Johnson, Jr., and Franklin Advisers, Inc. (FAV), have filed an amendment to their Schedule 13D for Clarion Partners Real Estate Income Fund Inc. The filing reports that FRI and its investment management subsidiaries, including FAV, beneficially ow...

This Amendment No. 4B to the Schedule 13D filed by Howard W. Lutnick indicates that he no longer has any voting or dispositive power over the securities of Cantor Equity Partners, Inc. The amendment reflects the completion of Mr. Lutnick's divestiture of his holdings in Cantor and CFGM, which was finalized on October 6...

This filing, Amendment No. 4A to Schedule 13D, pertains to the beneficial ownership of Class A and Class B ordinary shares of Cantor Equity Partners, Inc. by Cantor EP Holdings, LLC, Cantor Fitzgerald, L.P., CF Group Management, Inc., and Brandon G. Lutnick. The amendment reflects the completion of Howard W. Lutnick's ...

Howard W. Lutnick, former CEO and Chairman of BGC Group, Inc., has completed the divestiture of his holdings in the company. This action follows his appointment as the U.S. Secretary of Commerce. The divestiture was finalized on October 6, 2025, resulting in Lutnick no longer holding any voting or dispositive power ove...

Amendment No. 20A to Schedule 13D for BGC Group, Inc. details the completion of Howard W. Lutnick's divestiture of his holdings in the company following his appointment as U.S. Secretary of Commerce. The amendment outlines several transactions, including the sale of voting shares of CF Group Management, Inc. (CFGM) to ...

This Amendment No. 4 to Schedule 13D, filed by Dipan Patel, updates the ownership details of Class A Common Stock of Amneal Pharmaceuticals, Inc. As of the filing date, Patel beneficially owns 23,828,992 shares, representing 7.6% of the outstanding Class A Common Stock. The amendment also includes details of a Second M...